Home Bancorp, Inc. (NASDAQ:HBCP) shares decreased -0.28% in last trading session and ended the day at $25.28. HBCP has a return on assets of 0.90%. Home Bancorp, Inc. (NASDAQ:HBCP) quarterly performance is -4.10%.
Zacks Investment Research upgraded shares of Home Bancorp, Inc. (NASDAQ:HBCP) from a hold rating to a buy rating in a report published on Friday, Analyst Ratings Network.com reports. Zacks Investment Research currently has $27.00 target price on the stock.
Big 5 Sporting Goods Corp. (NASDAQ:BGFV) ended the last trading day at $12.17. Company weekly volatility is calculated as 6.88% and price to cash ratio as 46.10. Big 5 Sporting Goods Corp. (NASDAQ:BGFV) showed a weekly performance of -8.56%.
On 1 March, Big 5 Sporting Goods Corp. (NASDAQ:BGFV) reported financial results for the fiscal 2015 fourth quarter and full year ended January 3, 2016. As the Company previously reported, net sales for the fiscal 2015 fourth quarter increased to $275.0 million from net sales of $250.3 million for the fourth quarter of fiscal 2014. Same store sales increased 0.1% for the fourth quarter of fiscal 2015.
MetLife, Inc. (NYSE:MET) shares moved down -0.14% in last trading session and ended the day at $42.33. MET has a return on assets of 0.60%. MetLife, Inc. (NYSE:MET) quarterly performance is -16.04%.
MetLife, Inc. (NYSE:MET) announced that it will hold an investor conference on Thursday, Sept. 29, 2016, in New York City. Presenters will include members of MetLife’s senior management team.
ArcelorMittal SA (ADR) (NYSE:MT) caters to the Basic Materials space. It has a net profit margin of -12.50% and weekly performance is 37.39%. On the last day of trading company shares ended up at $4.85. ArcelorMittal SA (ADR) (NYSE:MT) distance from 50-day simple moving average (SMA50) is 28.78%.
ArcelorMittal SA (ADR) (NYSE:MT) announced An extraordinary general shareholders meeting has been called for March 10, 2016 to consider, among other things, the increase in ArcelorMittal’s authorized share capital necessary to permit the launch of the proposed rights offering.
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) caters to the Healthcare space. Its weekly performance is 62.50%. On the last day of trading company shares ended up at $7.54. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) distance from 50-day simple moving average (SMA50) is 1.66%.
On 4 March, InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) reported financial results for the year ended December 31, 2015. For the year ended December 31, 2015, InVivo reported a net loss of approximately $33,314,000, or $1.26 per diluted share, compared to a loss of $18,346,000, or $0.83 per diluted share, for the year ending December 31, 2014.
Leave a Reply